4.5 Article

Heterozygous deletion of the LRFN2 gene is associated with working memory deficits

Journal

EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 24, Issue 6, Pages 911-918

Publisher

SPRINGERNATURE
DOI: 10.1038/ejhg.2015.221

Keywords

-

Funding

  1. regional council of Burgundy
  2. NIDCD/NIH

Ask authors/readers for more resources

Learning disabilities (LDs) are a clinically and genetically heterogeneous group of diseases. Array-CGH and high-throughput sequencing have dramatically expanded the number of genes implicated in isolated intellectual disabilities and LDs, highlighting the implication of neuron-specific post-mitotic transcription factors and synaptic proteins as candidate genes. We report a unique family diagnosed with autosomal dominant learning disability and a 6p21 microdeletion segregating in three patients. The 870 kb microdeletion encompassed the brain-expressed gene LRFN2, which encodes for a synaptic cell adhesion molecule. Neuropsychological assessment identified selective working memory deficits, with borderline intellectual functioning. Further investigations identified a defect in executive function, and auditory-verbal processes. These data were consistent with brain MRI and FDG-PET functional brain imaging, which, when compared with controls, revealed abnormal brain volume and hypometabolism of gray matter structures implicated in working memory. We performed electron microscopy immunogold labeling demonstrating the localization of LRFN2 at synapses of cerebellar and hippocampal rat neurons, often associated with the NR1 subunit of N-methyl-D-aspartate receptors (NMDARs). Altogether, the combined approaches imply a role for LRFN2 in LD, specifically for working memory processes and executive function. In conclusion, the identification of familial cases of clinically homogeneous endophenotypes of LD might help in both the management of patients and genetic counseling for families.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum

Ange-Line Bruel, Antonio Vitobello, Isabelle Thiffault, Linda Manwaring, Marcia Willing, Pankaj B. Agrawal, Allan Bayat, Thomas M. Kitzler, Catherine A. Brownstein, Casie A. Genetti, Joseph Gonzalez-Heydrich, Parul Jayakar, Jacob W. Zyskind, Zehua Zhu, Clemence Vachet, Gena R. Wilson, Brianna Pruniski, Anne-Marie Goyette, Yannis Duffourd, Christel Thauvin-Robinet, Christophe Philippe, Laurence Faivre

Summary: The study confirms the important role of the ITSN1 gene in neurodevelopmental disorders such as autism. Truncating variants and missense variants in ITSN1 exhibit different patterns and symptoms in affected patients.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Biochemistry & Molecular Biology

Accelerated genome sequencing with controlled costs for infants in intensive care units: a feasibility study in a French hospital network

Anne-Sophie Denomme-Pichon, Antonio Vitobello, Robert Olaso, Alban Ziegler, Mederic Jeanne, Frederic Tran Mau-Them, Victor Couturier, Caroline Racine, Bertrand Isidor, Charlotte Poe, Thibaud Jouan, Anne Boland, Bertrand Fin, Delphine Bacq-Daian, Celine Besse, Aurore Garde, Adeline Prost, Philippine Garret, Emilie Tisserant, Julian Delanne, Sophie Nambot, Aurelien Juven, Magali Gorce, Mathilde Nizon, Marie Vincent, Sebastien Moutton, Melanie Fradin, Alinoe Lavillaureix, Paul Rollier, Yline Capri, Julien Van-Gils, Tiffany Busa, Sabine Sigaudy, Laurent Pasquier, Magalie Barth, Ange-Line Bruel, Cyril Flamant, Clement Prouteau, Dominique Bonneau, Annick Toutain, Corinne Chantegret, Patrick Callier, Christophe Philippe, Yannis Duffourd, Jean-Francois Deleuze, Arthur Sorlin, Laurence Faivre, Christel Thauvin-Robinet

Summary: Accelerated trio-genome sequencing (GS) is valuable for infants with early-onset rare diseases in urgent care contexts, leading to molecular diagnosis with corrective measures and protocol adaptations. A circuit with rapid or ultra-rapid GS should coexist, with decreasing costs resulting in generalized use for diagnostic purposes and reduction of the costs of rapid GS.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Oncology

Detecting inversions in routine molecular diagnosis in MMR genes

Edwige Kasper, Sophie Coutant, Sandrine Manase, Stephanie Vasseur, Pierre Macquere, Gaelle Bougeard, Laurence Faivre, Olivier Ingster, Stephanie Baert-Desurmont, Claude Houdayer

Summary: Inversions, a known cause of human diseases, are often overlooked. This study highlights the importance of inversion detection in routine diagnosis through case examples from two families.

FAMILIAL CANCER (2022)

Article Genetics & Heredity

CDK13-related disorder: Report of a series of 18 previously unpublished individuals and description of an epigenetic signature

Flavien Rouxel, Raissa Relator, Jennifer Kerkhof, Haley McConkey, Michael Levy, Patricia Dias, Mouna Barat-Houari, Nathalie Bednarek, Odile Boute, Nicolas Chatron, Florian Cherik, Andree Delahaye-Duriez, Martine Doco-Fenzy, Laurence Faivre, Lucas W. Gauthier, Delphine Heron, Michael S. Hildebrand, Gaetan Lesca, James Lespinasse, Benoit Mazel, Leonie A. Menke, Angela T. Morgan, Lucile Pinson, Chloe Quelin, Massimiliano Rossi, Nathalie Ruiz-Pallares, Frederic Tran-Mau-Them, Imke N. Van Kessel, Marie Vincent, Mathys Weber, Marjolaine Willems, Gwenael Leguyader, Bekim Sadikovic, David Genevieve

Summary: This study reports the clinical features and genome-wide DNA methylation characterization of 18 novel individuals with CDK13-related disorder (CDK13-RD). The results reveal a global hypomethylated profile in CDK13-RD individuals and suggest the potential diagnostic utility of CDK13-RD DNA methylation episignature.

GENETICS IN MEDICINE (2022)

Review Genetics & Heredity

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

Juliette Coursimault, Anne-Marie Guerrot, Michelle M. Morrow, Catherine Schramm, Francisca Millan Zamora, Anita Shanmugham, Shuxi Liu, Fanggeng Zou, Frederic Bilan, Gwenael Le Guyader, Ange-Line Bruel, Anne-Sophie Denomme-Pichon, Laurence Faivre, Frederic Tran Mau-Them, Marine Tessarech, Estelle Colin, Salima El Chehadeh, Benedicte Gerard, Elise Schaefer, Benjamin Cogne, Bertrand Isidor, Mathilde Nizon, Diane Doummar, Stephanie Valence, Delphine Heron, Boris Keren, Cyril Mignot, Charles Coutton, Francoise Devillard, Anne-Sophie Alaix, Jeanne Amiel, Laurence Colleaux, Arnold Munnich, Karine Poirier, Marlene Rio, Sophie Rondeau, Giulia Barcia, Bert Callewaert, Annelies Dheedene, Candy Kumps, Sarah Vergult, Bjoern Menten, Wendy K. Chung, Rebecca Hernan, Austin Larson, Kelly Nori, Sarah Stewart, James Wheless, Christina Kresge, Beth A. Pletcher, Roseline Caumes, Thomas Smol, Sabine Sigaudy, Christine Coubes, Margaret Helm, Rosemarie Smith, Jennifer Morrison, Patricia G. Wheeler, Amy Kritzer, Guillaume Jouret, Alexandra Afenjar, Jean-Francois Deleuze, Robert Olaso, Anne Boland, Christine Poitou, Thierry Frebourg, Claude Houdayer, Pascale Saugier-Veber, Gael Nicolas, Francois Lecoquierre

Summary: Pathogenic variants of the MYT1L gene cause a syndromic neurodevelopmental disorder characterized by developmental delay, intellectual disability, overweight or obesity, behavioral disorders, and epilepsy. Additional clinical features include learning disabilities, feeding difficulties, and varied dysmorphic features. Highly clustered missense variants do not show significant clinical differences compared to truncating variants. This study provides updated clinical and genetic data for improved diagnosis and management of MYT1L-associated neurodevelopmental disorder patients.

HUMAN GENETICS (2022)

Article Genetics & Heredity

The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder

Smitha Kumble, Amanda M. Levy, Jaya Punetha, Hua Gao, Nicholas Ah Mew, Kwame Anyane-Yeboa, Paul J. Benke, Sara M. Berger, Lise Bjerglund, Belinda Campos-Xavier, Michael Ciliberto, Julie S. Cohen, Anne M. Comi, Cynthia Curry, Lena Damaj, Anne-Sophie Denomme-Pichon, Lisa Emrick, Laurence Faivre, Mary Beth Fasano, Alice Fievet, Richard S. Finkel, Sixto Garcia-Minaur, Amanda Gerard, Paulino Gomez-Puertas, Maria J. Guillen Sacoto, Trevor L. Hoffman, Lillian Howard, Alejandro D. Iglesias, Kosuke Izumi, Austin Larson, Anja Leiber, Reymundo Lozano, Inigo Marcos-Alcalde, Cassie S. Mintz, Sureni V. Mullegama, Rikke S. Moller, Sylvie Odent, Henry Oppermann, Elsebet Ostergaard, Marta Pacio-Miguez, Maria Palomares-Bralo, Sumit Parikh, Anna M. Paulson, Konrad Platzer, Jennifer E. Posey, Lorraine Potocki, Anya Revah-Politi, Marlene Rio, Alyssa L. Ritter, Scott Robinson, Jill A. Rosenfeld, Fernando Santos-Simarro, Sergio B. Sousa, Mathys Weber, Yili Xie, Wendy K. Chung, Natasha J. Brown, Zeynep Tumer

Summary: De novo variants in QRICH1 have been identified in individuals with intellectual disability, contributing to a neurodevelopmental disorder. The common clinical features include developmental delay, facial dysmorphism, and hypotonia, with additional findings of poor weight gain, short stature, autism spectrum disorder, seizures, and scoliosis. Some variants are inherited from mildly affected parents, suggesting variable expressivity.

HUMAN MUTATION (2022)

Article Genetics & Heredity

Clinical and genomic delineation of the new proximal 19p13.3 microduplication syndrome

Guillaume Jouret, Matthieu Egloff, Emilie Landais, Olivier Tassy, Fabienne Giuliano, Houda Karmous-Benailly, Charles Coutton, Veronique Satre, Francoise Devillard, Klaus Dieterich, Gaelle Vieville, Paul Kuentz, Cedric le Caignec, Claire Beneteau, Bertrand Isidor, Mathilde Nizon, Patrick Callier, Valentine Marquet, Eric Bieth, Jonathan Levy, Anne-Claude Tabet, Stanislas Lyonnet, Genevieve Baujat, Marlene Rio, Francois Cartault, Sophie Scheidecker, Aurelie Gouronc, Audrey Schalk, Clemence Jacquin, Marta Spodenkiewicz, Chloe Angelini, Perrine Pennamen, Caroline Rooryck, Martine Doco-Fenzy, Celine Poirsier

Summary: This study aims to better characterize the syndrome associated with duplications in the proximal 19p13.3 region. A large cohort of patients with 19p13.3 duplications was collected and analyzed to identify a new critical region. The findings suggest that these duplications may lead to structural abnormalities and gene misregulation, impacting the control of head circumference during development.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Review Genetics & Heredity

1p36 deletion syndrome: Review and mapping with further characterization of the phenotype, a new cohort of 86 patients

Clemence Jacquin, Emilie Landais, Celine Poirsier, Alexandra Afenjar, Ahmad Akhavi, Nathalie Bednarek, Caroline Benech, Adeline Bonnard, Damien Bosquet, Lydie Burglen, Patrick Callier, Sandra Chantot-Bastaraud, Christine Coubes, Charles Coutton, Bruno Delobel, Margaux Descharmes, Jean-Michel Dupont, Vincent Gatinois, Nicolas Gruchy, Sarah Guterman, Abdelkader Heddar, Lucas Herissant, Delphine Heron, Bertrand Isidor, Pauline Jaeger, Guillaume Jouret, Boris Keren, Paul Kuentz, Cedric Le Caignec, Jonathan Levy, Nathalie Lopez, Zoe Manssens, Dominique Martin-Coignard, Isabelle Marey, Cyril Mignot, Chantal Missirian, Celine Pebrel-Richard, Lucile Pinson, Jacques Puechberty, Sylvia Redon, Damien Sanlaville, Marta Spodenkiewicz, Anne-Claude Tabet, Alain Verloes, Gaelle Vieville, Catherine Yardin, Francois Vialard, Martine Doco-Fenzy

Summary: Chromosome 1p36 deletion syndrome is a common terminal deletion syndrome characterized by craniofacial features, developmental delay, hypotonia, epilepsy, and cardiac abnormalities. This study aims to evaluate the incidence of 1p36DS in the French population and compare it with other genetic syndromes, as well as refine the phenotype and improve patient management through genotype-phenotype correlation.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Genetics & Heredity

Further clinical and molecular characterization of an XLID syndrome associated with BRWD3 variants, a gene implicated in the leukemia-related JAK-STAT pathway

Julian Delanne, Magaly Lecat, Patrick R. Blackburn, Eric W. Klee, Constance T. R. M. Stumpel, Sander Stegmann, Servi J. C. Stevens, Caroline Nava, Delphine Heron, Boris Keren, Sonal Mahida, Sakkubai Naidu, Dusica Babovic-Vuksanovic, Johanna C. Herkert, Pernille M. Torring, Maria Kibaek, Isabelle De Bie, Rolph Pfundt, Yvonne M. C. Hendriks, Lilian Bomme Ousager, Renee Bend, Hannah Warren, Steven A. Skinner, Michael J. Lyons, Charlotte Poe, Martin Chevarin, Thibaud Jouan, Aurore Garde, Quentin Thomas, Paul Kuentz, Emilie Tisserant, Yannis Duffourd, Christophe Philippe, Laurence Faivre, Christel Thauvin-Robinet

Summary: Since the first description of a BRWD3-associated ID disorder in 2007, additional families have been reported. Using ES and international data sharing, we identified 14 additional individuals with pathogenic BRWD3 variants. We reviewed the previously published cases and described the phenotypes of 43 males and 2 females.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

Surgical management of Chiari malformation type 1 associated to MCAP syndrome and study of cerebellar and adjacent tissues for PIK3CA mosaicism

Federico Di Rocco, Maria Lucia Licci, Aurore Garde, Carmine Mottolese, Christel Thauvin-Robinet, Martin Chevarin, Laurent Guibaud, Pierre Vabres, Paul Kuentz, Laurence Faivre

Summary: This study reviewed two cases of children with Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP) who underwent surgical decompression for Chiari Malformation Type 1 (CM1). The PIK3CA variant allele frequency (VAF) was analyzed in cerebellar parenchyma and adjacent structures. The findings suggest that recognizing the comorbidity of CM1 in MCAP patients is crucial for personalized treatment and the variable PIK3CA VAF may explain the heterogeneity and severity of anomalies observed in MCAP patients.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2023)

Review Genetics & Heredity

TELO2-related syndrome (You-Hoover-Fong syndrome): Description of 14 new affected individuals and review of the literature

Daniah Albokhari, Amanda Barone Pritchard, Adelyn Beil, Candace Muss, Caleb Bupp, Dorothy K. Grange, Geoffroy Delplancq, Jennifer Heeley, Melissa Zuteck, Michelle M. Morrow, Paul Kuentz, Timothy Blake Palculict, Julie E. Hoover-Fong

Summary: You-Hoover-Fong syndrome (YHFS) is an autosomal recessive condition caused by pathogenic variants in the TELO2 gene. It is characterized by global developmental delay, intellectual disability, microcephaly, dysmorphic facial features, ocular involvement, movement disorder, hypertonia and spasticity, and abnormal sleep pattern. Other features include poor growth, cleft palate, cardiac malformations, epilepsy, scoliosis, and hearing loss. This study describes 14 new individuals with YHFS and provides additional support of the phenotype recognized previously. A review of the literature including follow-up data on four previously reported individuals with YHFS is also presented.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Biochemistry & Molecular Biology

BRAT1-related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients

Camille Engel, Stephanie Valence, Geoffroy Delplancq, Reza Maroofian, Andrea Accogli, Emanuele Agolini, Fowzan S. Alkuraya, Valentina Baglioni, Irene Bagnasco, Mathilde Becmeur-Lefebvre, Enrico Bertini, Ingo Borggraefe, Elise Brischoux-Boucher, Ange-Line Bruel, Alfredo Brusco, Dalal K. Bubshait, Christelle Cabrol, Maria Roberta Cilio, Marie-Coralie Cornet, Christine Coubes, Olivier Danhaive, Valerie Delague, Anne-Sophie Denomme-Pichon, Marilena Carmela Di Giacomo, Martine Doco-Fenzy, Hartmut Engels, Kirsten Cremer, Marion Gerard, Joseph G. Gleeson, Delphine Heron, Joanna Goffeney, Anne Guimier, Frederike L. Harms, Henry Houlden, Michele Iacomino, Rauan Kaiyrzhanov, Benjamin Kamien, Ehsan Ghayoor Karimiani, Dror Kraus, Paul Kuentz, Kerstin Kutsche, Damien Lederer, Lauren Massingham, Cyril Mignot, Deborah Morris-Rosendahl, Lakshmi Nagarajan, Sylvie Odent, Clothilde Ormieres, Jennifer Neil Partlow, Laurent Pasquier, Lynette Penney, Christophe Philippe, Gianluca Piccolo, Cathryn Poulton, Audrey Putoux, Marlene Rio, Christelle Rougeot, Vincenzo Salpietro, Ingrid Scheffer, Amy Schneider, Siddharth Srivastava, Rachel Straussberg, Pasquale Striano, Enza Maria Valente, Perrine Venot, Laurent Villard, Antonio Vitobello, Johanna Wagner, Matias Wagner, Maha S. Zaki, Federizo Zara, Gaetan Lesca, Vahid Reza Yassaee, Mohammad Miryounesi, Farzad Hashemi-Gorji, Mehran Beiraghi, Farah Ashrafzadeh, Hamid Galehdari, Christopher Walsh, Antonio Novelli, Moritz Tacke, Dinara Sadykova, Yerdan Maidyrov, Kairgali Koneev, Chingiz Shashkin, Valeria Capra, Mina Zamani, Lionel Van Maldergem, Lydie Burglen, Juliette Piard

Summary: BRAT1 biallelic variants are associated with two syndromes, one is a severe phenotype with rigidity and multifocal seizure, and the other is a milder phenotype with cerebellar atrophy. Genotype-phenotype correlations show that different variants are associated with different phenotypes, with nonsense and frameshift variants causing the severe phenotype, missense variants more likely associated with the milder phenotype, and splice variants showing variable phenotypes.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Cell Biology

Stepwise use of genomics and transcriptomics technologies increases diagnostic yield in Mendelian disorders

Estelle Colin, Yannis Duffourd, Martin Chevarin, Emilie Tisserant, Simon Verdez, Julien Paccaud, Ange-Line Bruel, Frederic Tran Mau-Them, Anne-Sophie Denomme-Pichon, Julien Thevenon, Hana Safraou, Thomas Besnard, Alice Goldenberg, Benjamin Cogne, Bertrand Isidor, Julian Delanne, Arthur Sorlin, Sebastien Moutton, Melanie Fradin, Christele Dubourg, Magali Gorce, Dominique Bonneau, Salima El Chehadeh, Francois-Guillaume Debray, Martine Doco-Fenzy, Kevin Uguen, Nicolas Chatron, Bernard Aral, Nathalie Marle, Paul Kuentz, Anne Boland, Robert Olaso, Jean-Francois Deleuze, Damien Sanlaville, Patrick Callier, Christophe Philippe, Christel Thauvin-Robinet, Laurence Faivre, Antonio Vitobello

Summary: Multi-omics technologies provide valuable and increasingly accessible tools for diagnostic laboratories to help patients with unresolved rare diseases, especially those clinically diagnosed with rare OMIM diseases. However, there is currently no consensus on the optimal diagnostic care pathway to follow after negative results with standard approaches.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Genetics & Heredity

Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations

Laurence Faivre, Jean-Charles Crepin, Manon Reda, Sophie Nambot, Virginie Carmignac, Caroline Abadie, Tristan Mirault, Cecile Faure-Conter, Juliette Mazereeuw-Hautier, Aude Maza, Eve Puzenat, Marie-Agnes Collonge-Rame, Anne-Claire Bursztejn, Christophe Philippe, Christel Thauvin-Robinet, Martin Chevarin, Claire Abasq-Thomas, Jeanne Amiel, Stephanie Arpin, Sebastien Barbarot, Genevieve Baujat, Didier Bessis, Emmanuelle Bourrat, Odile Boute, Nicolas Chassaing, Christine Coubes, Benedicte Demeer, Patrick Edery, Salima El Chehadeh, Alice Goldenberg, Smail Hadj-Rabia, Damien Haye, Bertrand Isidor, Marie-Line Jacquemont, Philippe Khau Van Kien, Didier Lacombe, Daphne Lehalle, Laetitia Lambert, Ludovic Martin, Annabel Maruani, Fanny Morice-Picard, Florence Petit, Alice Phan, Lucile Pinson, Massimiliano Rossi, Renaud Touraine, Clemence Vanlerberghe, Marie Vincent, Catherine Vincent-Delorme, Sandra Whalen, Marjolaine Willems, Nathalie Marle, Virginie Verkarre, Christine Devalland, Mojgan Devouassoux-Shisheboran, Marine Abad, Nathalie Rioux-Leclercq, Bertille Bonniaud, Yannis Duffourd, Jehanne Martel, Christine Binquet, Paul Kuentz, Pierre Vabres

Summary: The PIK3CA-related overgrowth spectrum (PROS) is a group of conditions caused by mosaic activating PIK3CA variants. These variants are also involved in various types of cancer. Abdominal ultrasound surveillance has been recommended for detecting Wilms tumor (WT) in PROS. Our study aimed to determine the risk of tumors in PROS patients and evaluate the relevance of surveillance.

CLINICAL GENETICS (2023)

Meeting Abstract Biochemistry & Molecular Biology

Low risk of embryonal cancer in PIK3CA-Related Overgrowth Spectrum: impact on screening recommendations

Laurence Faivre, Jean-Charles Crepin, Manon Reda, Sophie Nambot, Virginie Carmignac, Caroline Abadie, Audrey Putoux, Juliette Mazereeuw-Hautier, Aude Maza, Maxime Luu, Yannis Duffourd, Christophe Philippe, Christel Thauvin-Robinet, Martin Chevarin, Claire Abasq-Thomas, Jeanne Amiel, Stephanie Arpin, Genevieve Baujat, Didier Bessis, Emmanuelle Bourrat, Odile Boute, Anne-Claire Bursztejn, Nicolas Chassaing, Christine Coubes, Patrick Edery, Salima El Chehadeh, Alice Goldenberg, Smail Hadj-Rabia, Damien Haye, Bertrand Isidor, Marie-Line Jacquemont, Didier Lacombe, Bruno Leheup, Ludovic Martin, Anabel Maruani, Fanny Morice-Picard, Florence Petit, Alice Phan, Lucille Pinson, Eve Puzenat, Massimiliano Rossi, Renaud Touraine, Clemence Vanlerberghe, Marie Vincent, Catherine Vincent-Delorme, Sandra Whalen, Marjolaine Willems, Tristan Mirault, Paul Kuentz, Pierre Vabres

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

No Data Available